scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1734-1140(13)71081-8 |
P698 | PubMed publication ID | 24145094 |
P50 | author | Magdalena Jastrzębska-Więsek | Q59703080 |
Monika Marcinkowska | Q59822638 | ||
Agata Siwek | Q91209754 | ||
Marcin Kolaczkowski | Q91350780 | ||
Grzegorz Kazek | Q114331031 | ||
Anna Partyka | Q58958203 | ||
Anna Wesołowska | Q58958243 | ||
P2093 | author name string | Barbara Nawieśniak | |
P2860 | cites work | 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture | Q72110315 |
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor | Q24310557 | ||
Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue | Q24674871 | ||
Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways | Q24675480 | ||
Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 | Q28236198 | ||
Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells | Q28243874 | ||
5-ht6 receptors | Q28245286 | ||
Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders | Q28260500 | ||
A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation | Q28263452 | ||
2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists | Q28264695 | ||
Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data | Q33706897 | ||
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists | Q33923475 | ||
E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat. | Q34111024 | ||
Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression. | Q34576271 | ||
SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. | Q34577251 | ||
Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation | Q34618354 | ||
Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats. | Q34673522 | ||
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist | Q34703801 | ||
5-HT6 receptors: a novel target for cognitive enhancement | Q36187762 | ||
Partial agonists, full agonists, antagonists: dilemmas of definition | Q36741987 | ||
5-HT6 receptor signal transduction second messenger systems | Q37809903 | ||
Behavioral pharmacology: potential antidepressant and anxiolytic properties. | Q37844224 | ||
Neonatal serotonin (5-HT) depletion does not affect spatial learning and memory in rats | Q39608475 | ||
Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. | Q46080371 | ||
Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s. | Q46568729 | ||
Acute and repeated treatment with the 5-HT7 receptor antagonist SB 269970 induces functional desensitization of 5-HT7 receptors in rat hippocampus | Q48484963 | ||
P433 | issue | 4 | |
P304 | page(s) | 998-1005 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | Pharmacological Reports | Q15766499 |
P1476 | title | Partial agonist efficacy of EMD386088, a 5-HT6 receptor ligand, in functional in vitro assays | |
P478 | volume | 65 |
Q38298300 | Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats. |
Q47587262 | Dorsomedial prefrontal cortex 5-HT6 receptors regulate anxiety-like behavior |
Q36273778 | Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity |
Q38627971 | Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease. |
Q42323374 | Metabolic and Cardiovascular Benefits and Risks of EMD386088-A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor |
Q39134334 | Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status |
Q28275114 | Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats |
Q47996823 | Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats. |